Pancreatic Cancer Research

ResearcherChinese Academy of SciencesActive in the last 2 years

Wenxiu Xin

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-5491-4930; OpenAlex author ID A5073273798. Sources: OpenAlex.

Their work

Papers
4 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
5
Papers, trials and grants by year

2018: 1 paper · 2019: none · 2020: none · 2021: none · 2022: none · 2023: 2 papers · 2024: none · 2025: 1 paper

Papers 4

  1. miR-135b-5p/PDE3B Axis Regulates Gemcitabine Resistance in Pancreatic Cancer Through Epithelial-Mesenchymal Transition. Last author DOI 10.1002/mc.23914↗
  2. Identification and validation of the microRNAs and hub genes for pancreatic ductal adenocarcinoma by an integrated bioinformatic analysis. Co-author DOI 10.21037/jgo-23-192↗
  3. Correlation of gene expression profiles to identify pancreatic cancer cell lines that best model primary human tumors. Co-author DOI 10.21037/tcr-23-173↗
  4. Effects of metformin on survival outcomes of pancreatic cancer patients with diabetes: A meta-analysis. Co-author DOI 10.3892/mco.2017.1541↗

Closest collaborators

The 5 strongest of 5 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Yuxuan Fu · 2 shared papers, 2023–2025 · strength 0.46
  2. Yan Ping Hu · 2 shared papers, 2023 · strength 0.36
  3. Fang Luo · 2 shared papers, 2023 · strength 0.36
  4. Luo Fang · 1 shared paper, 2018 · strength 0.11
  5. Ping Cheong Huang · 1 shared paper, 2018 · strength 0.11

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.